BusinessMultiple Programs Featuring Poseida Therapeutics’ Advanced CAR-T Therapies Presented at American Society of Hematology 2017 Annual MeetingBy Nasdaq OMXDec 11, 2017, 1:01 PM UTC
BusinessRafael Pharmaceuticals to Present New Data Validating Efficacy of CPI-613 in Treating Acute Myeloid Leukemia at the 2017 American Society of Hematology Annual Meeting & ExpositionBy Nasdaq OMXDec 7, 2017, 1:55 PM UTC
BusinessCaelum Biosciences Announces Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 59th American Society of Hematology Annual MeetingBy Nasdaq OMXNov 1, 2017, 1:05 PM UTC
BusinessPoseida Therapeutics Presents Preclinical Data Demonstrating Tumor Response from BCMA-Specific CAR-T Program at American Society of Hematology Annual MeetingBy Nasdaq OMXDec 5, 2016, 6:00 PM UTC
BusinessPoseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual MeetingBy Nasdaq OMXNov 3, 2016, 1:00 PM UTC